Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination

BACKGROUND: Antibodies against cationic platelet chemokine, platelet factor 4 (PF4/CXCL4), have been described in heparin-induced thrombocytopenia (HIT), but also in patients positive for antiphospholipid antibodies (aPL) even in the absence of heparin treatment and HIT-related clinical manifestatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lonati, Paola Adele, Bodio, Caterina, Scavone, Mariangela, Martini, Giuliana, Pesce, Elisa, Bandera, Alessandra, Lombardi, Andrea, Gerosa, Maria, Franceschini, Franco, Tincani, Angela, Podda, Gianmarco, Abrignani, Sergio, Grifantini, Renata, Cattaneo, Marco, Borghi, Maria Orietta, Meroni, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822540/
https://www.ncbi.nlm.nih.gov/pubmed/35131751
http://dx.doi.org/10.1136/rmdopen-2021-001902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822540/
https://www.ncbi.nlm.nih.gov/pubmed/35131751
http://dx.doi.org/10.1136/rmdopen-2021-001902

Ejemplares similares